JPMorgan plans to price trigger phoenix autocallable notes linked to BioMarin Pharmaceutical

By Toni Weeks

San Luis Obispo, Calif., Jan. 13 – JPMorgan Chase & Co. plans to price trigger phoenix autocallable optimization securities due July 22, 2016 linked to BioMarin Pharmaceutical Inc. shares, according to an FWP filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 11% to 14% if the stock closes at or above the coupon barrier, 65% of the initial share price, on any quarterly observation date.

The notes will be called at par if BioMarin Pharmaceutical shares close at or above the initial share price on any quarterly observation date.

The payout at maturity will be par unless the stock finishes below the 65% trigger level, in which case investors will be fully exposed to any losses.

The exact terms will be set at pricing.

J.P. Morgan Securities LLC and UBS Financial Services Inc. are the agents.

The notes will price Jan. 16 and settle Jan. 22.

The Cusip number is 48127R883.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.